Internal Medicine · New York, NY
NPI
1609855394
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
314 West 14th St, 5th Floor
New York, NY, 10014
Phone (212) 620-0144
Medicare paid, 2024
$10K
120 services
Medicare patients, 2024
92
Average age 73
Drug cost, 2024
$2.4M
3,592 prescriptions
Company payments, 2025
$29.63
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen M Dillon was code 99214 (office e&m - established), 38 times for 37 patients. In total Stephen M Dillon billed 120 services in 12 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 38 | 37 | $84.38 | $3,206 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 31 | 31 | $142.73 | $4,425 |
| 99213 Office E&M - Established | Office | 28 | 27 | $58.68 | $1,643 |
By year: 2022 $62K for 790 services; 2023 $65K for 796 services; 2024 $10K for 120 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen M Dillon prescribed most often to Medicare patients was Atorvastatin Calcium, with 233 prescriptions and refills. In total Stephen M Dillon wrote 3,592 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 233 | 550 | 73 | $1,320 |
| Rosuvastatin Calcium Generic | 186 | 359 | 53 | $1,381 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 177 | 205 | 27 | $836K |
| Valacyclovir Valacyclovir Hcl | 171 | 257 | 39 | $7,640 |
| Losartan Potassium Generic | 140 | 308 | 45 | $865 |
| Descovy Emtricitabine/Tenofov Alafenam | 101 | 109 | 15 | $244K |
| Bupropion Xl Bupropion Hcl | 101 | 157 | 15 | $2,215 |
| Gabapentin Generic | 97 | 109 | 16 | $840 |
| Tivicay Dolutegravir Sodium | 94 | 94 | 13 | $270K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 88 | 90 | 13 | $348K |
| Escitalopram Oxalate Generic | 84 | 163 | 19 | $516 |
| Amlodipine Besylate Generic | 72 | 162 | 20 | $354 |
| Metformin Hcl Generic | 67 | 116 | 16 | $283 |
| Levothyroxine Sodium Generic | 67 | 145 | 20 | $453 |
| Isentress Raltegravir Potassium | 62 | 72 | 11 | $145K |
Brand drugs: 778 claims; generic drugs: 2,792 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen M Dillon $29.63 ($29.63 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $29.63.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $29.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.